MFS
BIO icon

Mirabella Financial Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mirabella Financial Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,040
Closed -$4.97M – 343
2022
Q2 		$4.97M Buy
10,040
+4,775
+91% +$2.49M 0.49% 41
2022
Q1 		$2.97M Sell
5,265
-10,495
-67% -$6.33M 0.34% 49
2021
Q4 		$11.9M Buy
15,760
+9,012
+134% +$6.74M 1.21% 10
2021
Q3 		$5.03M Sell
6,748
-6,398
-49% -$4.79M 0.66% 43
2021
Q2 		$8.47M Sell
13,146
-689
-5% -$419K 1.63% 11
2021
Q1 		$7.9M Buy
13,835
+3,829
+38% +$2.27M 2.47% 6
2020
Q4 		$5.83M Buy
10,006
+8,912
+815% +$5.08M 0.73% 54
2020
Q3 		$564K Buy
+1,094
New +$554K 0.16% 126

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return